{"disease":{"id":"cataplexy","name":"cataplexy"},"drugs":{"marketed":[{"drug_id":"xyrem","indication_name":"Cataplexy and narcolepsy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Xyrem","company_name":"Jazz Pharmaceuticals","drug_phase":"marketed","molecular_target":"Calcium/calmodulin-dependent protein kinase type II subunit alpha, GABA-B receptor, Gamma-hydroxybutyrate receptor","drug_class":"","quality_score":16,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02720744","title":"Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":212,"lead_sponsor_name":"Avadel","has_results":true},{"nct_id":"NCT03030599","title":"A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":201,"lead_sponsor_name":"Jazz Pharmaceuticals","has_results":true},{"nct_id":"NCT04451668","title":"An Open Label Study of FT218 in Subjects With Narcolepsy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":184,"lead_sponsor_name":"Avadel","has_results":false},{"nct_id":"NCT05615584","title":"Spectrometry (MRM) Versus I 125 Radioimmunoassay (RIA) for Quantification of Orexin-A of Patients With Hypersomnolence","phase":"NA","overall_status":"RECRUITING","enrollment_count":117,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT02611687","title":"Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label Period","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"Bioprojet","has_results":true},{"nct_id":"NCT05059223","title":"A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Axsome Therapeutics, Inc.","has_results":false},{"nct_id":"NCT07363720","title":"A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":88,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT04026958","title":"Clarithromycin Mechanisms in Hypersomnia Syndromes","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":83,"lead_sponsor_name":"Emory University","has_results":false},{"nct_id":"NCT04419792","title":"'A Profile of Physical Performance Variables in an Out-patient Adult Population With Narcolepsy'","phase":"","overall_status":"SUSPENDED","enrollment_count":70,"lead_sponsor_name":"University of Dublin, Trinity College","has_results":false},{"nct_id":"NCT05113745","title":"A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Axsome Therapeutics, Inc.","has_results":false},{"nct_id":"NCT04923594","title":"Four-week Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in the Treatment of Narcolepsy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"NLS Pharmaceutics","has_results":false},{"nct_id":"NCT03425214","title":"Exploration of the Reward System by Functional MRI in Narco-cataplexy Patients With and Without REM Sleep Behavior Disorder","phase":"NA","overall_status":"UNKNOWN","enrollment_count":66,"lead_sponsor_name":"University Hospital, Clermont-Ferrand","has_results":false},{"nct_id":"NCT04306952","title":"Awareness and Self-Compassion Enhancing Narcolepsy Treatment","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Northwestern University","has_results":true},{"nct_id":"NCT05055024","title":"An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"NLS Pharmaceutics","has_results":false},{"nct_id":"NCT05914194","title":"A Eight-Week Study of NLS-2 (Mazindol Extended Release) in Participants With Narcolepsy Type 1","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":48,"lead_sponsor_name":"NLS Pharmaceutics","has_results":false},{"nct_id":"NCT03772314","title":"Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Emory University","has_results":true},{"nct_id":"NCT00345800","title":"Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"UCB Pharma SA","has_results":true},{"nct_id":"NCT03881852","title":"Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Axsome Therapeutics, Inc.","has_results":true},{"nct_id":"NCT05709873","title":"Narcolepsy Nightmare Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":7,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT03433131","title":"Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Harmony Biosciences Management, Inc.","has_results":false}],"total":20},"guidelines":[],"source":"Drug Landscape verified database"}